Hua Medicine (Shanghai) Balance Sheet Health
Financial Health criteria checks 5/6
Hua Medicine (Shanghai) has a total shareholder equity of CN¥101.2M and total debt of CN¥124.0M, which brings its debt-to-equity ratio to 122.6%. Its total assets and total liabilities are CN¥1.7B and CN¥1.6B respectively.
Key information
122.6%
Debt to equity ratio
CN¥124.04m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥1.46b |
| Equity | CN¥101.15m |
| Total liabilities | CN¥1.62b |
| Total assets | CN¥1.73b |
Recent financial health updates
Is Hua Medicine (Shanghai) (HKG:2552) Using Too Much Debt?
Nov 17
We Think Hua Medicine (Shanghai) (HKG:2552) Can Afford To Drive Business Growth
Jan 06We're Interested To See How Hua Medicine (Shanghai) (HKG:2552) Uses Its Cash Hoard To Grow
Aug 02Companies Like Hua Medicine (Shanghai) (HKG:2552) Can Afford To Invest In Growth
Apr 22Companies Like Hua Medicine (Shanghai) (HKG:2552) Can Afford To Invest In Growth
Sep 23We're Not Worried About Hua Medicine (Shanghai)'s (HKG:2552) Cash Burn
Jun 24Recent updates
Is Hua Medicine (Shanghai) (HKG:2552) Using Too Much Debt?
Nov 17Investors Appear Satisfied With Hua Medicine (Shanghai) Ltd.'s (HKG:2552) Prospects
Aug 28We Think Hua Medicine (Shanghai) (HKG:2552) Can Afford To Drive Business Growth
Jan 06We're Interested To See How Hua Medicine (Shanghai) (HKG:2552) Uses Its Cash Hoard To Grow
Aug 02Companies Like Hua Medicine (Shanghai) (HKG:2552) Can Afford To Invest In Growth
Apr 22Companies Like Hua Medicine (Shanghai) (HKG:2552) Can Afford To Invest In Growth
Sep 23We're Not Worried About Hua Medicine (Shanghai)'s (HKG:2552) Cash Burn
Jun 24Companies Like Hua Medicine (Shanghai) (HKG:2552) Can Afford To Invest In Growth
Mar 22Hua Medicine (Shanghai) Ltd.'s (HKG:2552) Profit Outlook
Feb 21Hua Medicine (Shanghai) (HKG:2552) Shareholders Booked A 21% Gain In The Last Year
Jan 25
Hua Medicine (Shanghai) (HKG:2552) Is In A Strong Position To Grow Its Business
Dec 21Financial Position Analysis
Short Term Liabilities: 2552's short term assets (CN¥1.6B) exceed its short term liabilities (CN¥252.0M).
Long Term Liabilities: 2552's short term assets (CN¥1.6B) exceed its long term liabilities (CN¥1.4B).
Debt to Equity History and Analysis
Debt Level: 2552 has more cash than its total debt.
Reducing Debt: 2552's debt to equity ratio has increased from 0% to 122.6% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 2552 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 2552 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 34.3% per year.